| Project Title | Molecularly Targeted Anti-Cancer Therapies |
| Date Posted | Wednesday, January 24, 2018 |
| Project ID | MSY4_STR045-046 |
| Status | Complete |
| Deliverables | |
| Description | These reports look at the use of 18 selected generic drug products relating to molecularly targeted anti-cancer therapies in the Mini-Sentinel Distributed Database (MSDD). These results were generated using the Mini-Sentinel Distributed Query Tool. This query was run against the Dispensing Summary Table and distributed on May 10, 2013 to 17 Data Partners; this report includes information from 17 Data Partners. |
| Medical Product | axitinib bicalutamide crizoatinib dasatinib erlotinib HCL everolimus gefitinib imatinib mesylate lapatinib ditosylate nilotinib HCL pazopanib HCL ruxolitinib phosphate sorafenib tosylate sunitinib malate tamoxifen citrate vandetanib vemurafenib vismodegib |
| Population / Cohort | All individuals |
| Time Period | 2000 - 2012 |
| Assessment Type | Exploratory Analyses |
| Study Type | Summary Table |
| Data Sources | Mini-Sentinel Distributed Database (MSDD) |
| FDA Center | CDER |
